Get notified when OTLK files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: OTLK Outlook Therapeutics, Inc. 8-K

Outlook Therapeutics reports Q2 FY2026 financial results for quarter ended March 31, 2026

Filed May 18, 2026 · Period ending May 15, 2026 · ~1 min read

Key Changes

  • medium

    Company issued press release announcing financial results for second fiscal quarter ending March 31, 2026. Actual financial figures and performance metrics are contained in the attached press release, not disclosed in the 8-K body.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade OTLK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · May 27, 2026 · How we verify